Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a glucose monitor personalize weight loss for students?

NCT ID NCT07818005

Disease control Sponsor: He Eye Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers examined whether dietary advice based on continuous glucose monitoring (CGM) helped overweight college students improve body weight and composition. The study analyzed archived records from 59 students who wore CGM sensors for four weeks; half received personalized diet guidance from their glucose responses, while the other half wore sensors without guidance. The analysis looks at changes in weight, body fat, and eating behavior at 28 and 90 days to see if the approach produced lasting benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
individualized dietary guidance based on continuous glucose monitoring
What this could lead to
If the approach works, it could offer a personalized way to help young adults manage weight using real-time glucose data rather than one-size-fits-all diets.
What could go wrong
This is a small retrospective analysis of 59 students at one university, so the findings may not apply broadly. The original study was short, and any changes in weight or body fat could fade without ongoing support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

59 people

The number who actually took part.

Started

Jun 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Overweight and obese university students (aged 18-25 years) at He University, Shenyang, Liaoning, China, whose records are contained in the archived dataset of a randomized controlled trial of a 4-week continuous glucose monitoring (CGM)-guided personalized dietary intervention. Participants had a body mass index (BMI) ≥ 24 kg/m² or elevated body fat percentage (≥ 25% in men, ≥ 32% in women) and self-reported at least two unhealthy eating behaviors. Of the 60 participants enrolled in the parent trial (30 per group), 59 were included in this retrospective analysis (30 exposed, 29 non-exposed); one non-exposed participant was excluded for missing primary outcome data. All participants were free of diabetes, prediabetes, and other exclusion conditions defined in the study protocol.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * University students aged 18 to 25 years * Body mass index (BMI) ≥ 24.0 kg/m², or body fat percentage ≥ 25% (male) / ≥ 32% (female) * Self-reported presence of at least two unhealthy eating behaviors * Written informed consent Exclusion Criteria:• Obesity due to endocrine diseases (e.g., Cushing's syndrome, hypothyroidism, hypothalamic obesity) or genetic syndromes * Polycystic ovary syndrome (PCOS) * Weight gain or glycemic abnormality induced by medications (e.g., glucocorticoids, antipsychotics, insulin secretagogues) * Diagnosed diabetes (type 1 or type 2) or prediabetes (fasting glucose ≥ 6.1 mmol/L or glycated hemoglobin (HbA1c)≥ 5.7%) * Diagnosed dyslipidemia with lipid-lowering medication * High risk of eating disorders identified by the Eating Disorder Diagnostic Scale (EDDS) * Severe psychiatric disorders or psychotropic medication use * Pregnancy, lactation, or planned pregnancy within 6 months * Allergy to CGM adhesive or hydrogel, or active skin disease affecting sensor wear * Professional athletes (high-intensity physical activity ≥ 5 times/week, ≥ 60 min/session) * Weight change \> 5% of initial body weight within the past 3 months * Participation in other commercial or clinical weight-loss programs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight/obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Feeding Behavior Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight/obesity Weight loss

Contacts and locations

Locations

  • He University, Shenyang, Liaoning, China

    Shenyang, Liaoning, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.